Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Yazar:	Khan, Mohd Shahnawaz
Diğer Yazarlar:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Baskı/Yayın Bilgisi:	Nature Publishing Group
Konular:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Online Erişim:	Citation/Abstract Full Text Full Text - PDF
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!